Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 113.41B | 148.84B | 73.68B | 64.83B | 55.07B | 50.11B |
Gross Profit | 110.28B | 0.00 | 73.68B | 64.83B | 55.07B | 50.11B |
EBITDA | 29.18B | 40.76B | 43.31B | 29.29B | 28.17B | 24.70B |
Net Income | 26.13B | 28.13B | 24.84B | 19.93B | 17.11B | 13.93B |
Balance Sheet | ||||||
Total Assets | 11.56T | 11.24T | 10.68T | 8.68T | 8.53T | 7.23T |
Cash, Cash Equivalents and Short-Term Investments | 1.95T | 0.00 | 1.67T | 1.10T | 1.77T | 1.51T |
Total Debt | 1.00T | 1.15T | 800.00B | 348.00B | 820.40B | 661.63B |
Total Liabilities | 11.40T | 11.07T | 10.52T | 348.00B | 820.40B | 661.63B |
Stockholders Equity | 164.40B | 169.94B | 151.61B | 131.60B | 145.36B | 133.66B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 106.42B | 541.44B | -960.25B | 451.25B | 259.97B |
Operating Cash Flow | 0.00 | 107.98B | 551.18B | -949.79B | 462.15B | 268.11B |
Investing Cash Flow | 0.00 | -835.44B | 15.35B | 312.76B | -205.61B | -39.80B |
Financing Cash Flow | 0.00 | 556.39B | -1.39B | -29.95B | -632.00M | 785.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $14.96T | 12.67 | 8.23% | 3.16% | 0.93% | 11.18% | |
76 Outperform | $11.25T | 12.75 | 8.69% | 2.75% | -1.99% | 23.19% | |
75 Outperform | $23.88T | 13.19 | 9.18% | 3.01% | 10.98% | 28.45% | |
70 Outperform | ¥734.93B | 26.75 | 0.39% | ― | ― | ||
67 Neutral | ¥757.60B | 11.12 | 7.57% | 3.18% | 7.70% | 14.02% | |
60 Neutral | $1.15T | 14.11 | 6.37% | 2.92% | 8.79% | 19.19% | |
42 Neutral | ¥306.73B | 14.37 | 4.62% | 3.70% | 1.12% | 6.36% |